ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,981Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 1313

$577K Total Retail Price of All Prescriptions

Rank: 140 out of 1313

669 Patients Receiving at Least One Drug in Part D
80% Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Maryland
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 669 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 669 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 510 444 137 1 2
SIMVASTATIN 416 359 129 2 5
ATORVASTATIN CALCIUM 388 349 96 3 4
ATENOLOL 353 321 93 4 16
AMLODIPINE BESYLATE 346 297 101 5 1
HYDROCHLOROTHIAZIDE 333 306 86 6 11
METOPROLOL TARTRATE 297 252 80 7 7
OMEPRAZOLE 255 176 67 8 8
WARFARIN SODIUM 251 223 57 9 13
LEVOTHYROXINE SODIUM 247 207 61 10 3
FUROSEMIDE 246 192 73 11 6
METFORMIN HCL 213 184 65 12 9
PRAVASTATIN SODIUM 166 153 48 13 10
TRAMADOL HCL 156 127 38 14 15
CLOPIDOGREL 155 123 43 15 18
METOPROLOL SUCCINATE 147 142* 41 16 14
MELOXICAM 135 112 32 17 61
PANTOPRAZOLE SODIUM 132 106 41 18 17
SERTRALINE HCL 131 90 32 19 20
LOSARTAN POTASSIUM 125 108 36 20 12
GLYBURIDE 113 100 31 R 21 126
LORAZEPAM 110 94 23 B 22 30
ALPRAZOLAM 108 103* 28 B 23 25
KLOR-CON M20 106 81 28 24 74
GABAPENTIN 105 74 30 25 19
PROAIR HFA 105 82 39 25 47
TAMSULOSIN HCL 98 79 24 27 27
ZOLPIDEM TARTRATE 97 65 28 28 28
SPIRIVA 92 75 27 29 67
AZITHROMYCIN 91 65 72 30 49
ISOSORBIDE MONONITRATE ER 80 62 22 31 66
CITALOPRAM HBR 77 54 17 32 31
ALLOPURINOL 74 69* 15 33 45
HYDROCODONE-ACETAMINOPHEN 72 58 24 S3 34 23
RANITIDINE HCL 71 47 21 35 29
LOVASTATIN 69 64* 19 36 38
DIAZEPAM 67 28 13 B 37 103
IBUPROFEN 67 48 26 37 78
VERAPAMIL ER 66 66 15 39 139
PAROXETINE HCL 66 61* 18 39 75
NEXIUM 65 49 15 41 44
FLUTICASONE PROPIONATE 63 40 27 42 34
DONEPEZIL HCL 63 63 11 42 24
CRESTOR 59 46 19 44 26
ESCITALOPRAM OXALATE 59 54* 13 44 42
POTASSIUM CHLORIDE 59 46 20 44 21
FLOVENT HFA 58 46 15 47 232
DIOVAN 57 <11 <11 48 41
CARVEDILOL 56 51* 19 49 32
AMOXICILLIN 53 36 47 50 120
CIPROFLOXACIN HCL 53 48* 30 50 64
ADVAIR DISKUS 51 46* 24 52 51
OXYBUTYNIN CHLORIDE 51 27 11 52 142
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.